TY - JOUR
T1 - Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua
AU - Fryer, John D.
AU - Yu, Peng
AU - Kang, Hyojin
AU - Mandel-Brehm, Caleigh
AU - Carter, Angela N.
AU - Crespo-Barreto, Juan
AU - Gao, Yan
AU - Flora, Adriano
AU - Shaw, Chad
AU - Orr, Harry T.
AU - Zoghbi, Huda Y.
PY - 2011/11/4
Y1 - 2011/11/4
N2 - Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by expansion of a translated CAG repeat in Ataxin-1 (ATXN1). To determine the long-term effects of exercise, we implemented a mild exercise regimen in a mouse model of SCA1 and found a considerable improvement in survival accompanied by up-regulation of epidermal growth factor and consequential down-regulation of Capicua, which is an ATXN1 interactor. Offspring of Capicua mutant mice bred to SCA1 mice showed significant improvement of all disease phenotypes. Although polyglutamine-expanded Atxn1 caused some loss of Capicua function, further reduction of Capicua levels - either genetically or by exercise - mitigated the disease phenotypes by dampening the toxic gain of function. Thus, exercise might have long-term beneficial effects in other ataxias and neurodegenerative diseases.
AB - Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by expansion of a translated CAG repeat in Ataxin-1 (ATXN1). To determine the long-term effects of exercise, we implemented a mild exercise regimen in a mouse model of SCA1 and found a considerable improvement in survival accompanied by up-regulation of epidermal growth factor and consequential down-regulation of Capicua, which is an ATXN1 interactor. Offspring of Capicua mutant mice bred to SCA1 mice showed significant improvement of all disease phenotypes. Although polyglutamine-expanded Atxn1 caused some loss of Capicua function, further reduction of Capicua levels - either genetically or by exercise - mitigated the disease phenotypes by dampening the toxic gain of function. Thus, exercise might have long-term beneficial effects in other ataxias and neurodegenerative diseases.
UR - http://www.scopus.com/inward/record.url?scp=80555125089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80555125089&partnerID=8YFLogxK
U2 - 10.1126/science.1212673
DO - 10.1126/science.1212673
M3 - Article
C2 - 22053053
AN - SCOPUS:80555125089
SN - 0036-8075
VL - 334
SP - 690
EP - 693
JO - Science
JF - Science
IS - 6056
ER -